MedTrace Logo

A Hospital-Based Registry of Preventive Cardiology Clinics

NCT06503341 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-04-13

No results posted yet for this study

Summary

More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes. Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive, effective treatment plan.

Conditions

  • Cardiovascular Morbidity
  • Cardiovascular Risk Assesment
  • Primary Prevention CVD

Interventions

OTHER

Cardiovascular risk assesment

ASCVD Score and WHO Cardiovascular Risk score.

Sponsors & Collaborators

  • National Institute of Cardiovascular Diseases, Pakistan

    lead OTHER

Principal Investigators

  • Dr Rubina Rauf · National Institute of Cardiovascular Diseases

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-17
Primary Completion
2031-06-01
Completion
2041-06-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06503341 on ClinicalTrials.gov